Outsourcing-pharma1d
Insights from Tjoapack’s CEO: 35 years of pharma packaging:
CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...
Outsourcing-pharma2d
Senhwa Biosciences starts trial of silmitasertib in children with difficult to treat cancers
The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...
Outsourcing-pharma2d
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Outsourcing-pharma4d
All news
Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.
Outsourcing-pharma4d
Starget Pharma’s AI-Driven Cancer Therapy Gains $5.1 Million Backing
Innovative radiotherapy offers a precision treatment alternative.
Outsourcing-pharma4d
Palomar Health inspires youth with hands-on medical program
Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.
Outsourcing-pharma4d
FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy
Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.
Outsourcing-pharma4d
Novo Nordisk’s semaglutide shows additional cardiovascular benefits in overweight patients
Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...